newsfilter
← Latest News
GlobeNewswire·

Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update

TUDRIQEV™ in combination with nivolumab receives FDA accelerated approval and will launch within 60 days Michelle DiNapoli appointed as Chief Commercial Officer Recently completed financing extends cash runway to